期刊文献+

腹膜透析相关性腹膜炎抗生素初始治疗方案探讨 被引量:13

Comparison of initial antibiotic therapies in peritoneal dialysis-related peritonitis
原文传递
导出
摘要 目的探讨头孢唑啉联合头孢他啶与万古霉素联合头孢他啶作为腹膜透析相关性腹膜炎初始治疗的效果。方法回顾性分析2006年1月至2009年5月在北京大学第三医院收治的合并腹膜透析相关性腹膜炎的患者90例。其中37例次采用头孢唑啉+头孢他啶治疗,97例次采用万古霉素+头孢他啶治疗。比较其初始治疗的有效率、最终转归、细菌培养和药物敏感试验情况。结果头孢哗啉+头孢他啶组患者腹膜炎的初始治疗有效率为81.1%,万古霉素+头孢他啶组为86.2%,两组间差异无统计学意义(P〉0.05);两组患者的G+细菌感染分别为56.8%和50.5%,差异无统计学意义(P〉0.05);两组患者在发病3周后治愈率分别为91.9%和97.9%,差异无统计学意义(P〉0.05)。结论头孢唑啉联合头孢他啶与万古霉素联合头孢他啶均可以作为腹膜透析相关性腹膜炎的初始治疗方案,且疗效相当。 Objective To evaluate the efficiency of cefazolin plus ceftazidime and vaneomycin plus ceftazidime as initial therapy for peritoneal dialysis (PD)-related peritonitis. Methods Retrospective analysis of 90 PD-related peritonitis from January 2006 to May 2009. Thirty-seven episodes were treated with cefazolin plus ceftazidime (CC group), and 97 episodes with vancomycin plus cefiazidime (VC group). Primary efficiency, outcomes, pathogenesis and resistance were analyzed respectively. Results The primary efficiency of CC group and VC group was 81.1% and 86.2%, respectively (P〉O.05). Gram-positive organisms of CC group and VC group was 56.8% and 50.5%, respectively (P〉0.05). The cure rate was 91.9% in CC group and 97.9% in VC group (P〉0.05). Conclusion Cefazolin plus cefiazidime and vancomycin plus ceftazidime have similar efficiency as an initial therapy for PD-related peritonitis.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2010年第2期95-98,共4页 Chinese Journal of Nephrology
关键词 腹膜透析 腹膜炎 头孢唑啉 万古霉素 Peritoneal dialysis Peritonitis Cefazolin Vaneomycin
  • 相关文献

参考文献15

  • 1Piraino B, Bailie GR, Bernardini J, et al. Peritoneal dialysis relaled infections recommendations: 2005 update.Perit Dial lnt, 2005, 25: 107-131.
  • 2Lui SL. Empirical antibiotie treatment for peritoneal dialysis related peritonitis: can "one size" fit all? Petit Dial lnt, 2007, 27: 48-50.
  • 3Keane WF, Everetl ED, Golper TA, et al. Peritoneal dialysis-related peritonitis treatment recommendations: 1993 update. Perit Dial Int, 1993, 13: 14-28.
  • 4Keane WF, Alexander SR, Bailie GR, et al. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Petit Dial lnt, 1996, 16: 557-573.
  • 5Keane WF, Bailie GR, Boeschutcn E, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int, 2000, 20: 396-411.
  • 6Lui SL, Cheng SW, Ng F, et al. Cefazolin plus netilmiein eetazolin plus eeftazidime for treating CAPD peritonitis: effect on residual renal function. Kidney Int, 2005, 68: 2375-2380.
  • 7Furgeson SB, Teitelbaum 1. New treatment options and protocols tbr peritoneal dialysis-related peritonitis. Contrib Nephrol, 2009, 163: 169-176.
  • 8Ktishnan M, Tbodis E, lkonomopoulos D, et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Petit Dial lnt, 2002, 22: 573-581.
  • 9郭群英,陈林,阳晓,杨念生,冯敏,姜宗培,毛海萍,陈崴,余学清.腹膜透析相关感染性腹膜炎致病菌及菌谱变化——单个腹膜透析中心15年回顾分析[J].中华肾脏病杂志,2006,22(12):719-724. 被引量:64
  • 10Ariano RE, Franezuk C, Fine A, et al. Challenging the current treatment paradigm for methieillinresistant staphyloeoeeus epidermidis peritonitis in peritoneal dialysis patients. Petit Dial lnt, 2002, 22: 335-338.

二级参考文献26

  • 1叶任高,肾脏病诊断与治疗学,1994年,586页
  • 2Keane WF, Bailie GR, Boesehoten E, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Petit Dial Int, 2000, 20:396-411.
  • 3Piraino B, Bailie GR, Bernardini J, et al. Peritoneal dialysisrelated infections recommendations: 2005 update. Petit Dial Int, 2005, 25:107-131.
  • 4Saito T, Iinuma Y, Takakura S, et al. Can BacT/Alert FA and FN blood culture bottles increase the recovery of microorganisms in the clinical laboratory? J Infect Chemother,2004, 10:343-347.
  • 5Zelenitsky S, Barns L, Findlay I, et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis, 2000, 36: 1009-1013.
  • 6Korbet SM, Vonesh EF, Firanek CA. Peritonitis in an urban peritoneal dialysis program: an analysis of infecting pathogens.Am J Kidney Dis, 1995, 26:47-53.
  • 7Bcmardini J, Hollcy JL, Johnston JR, ct al. An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol, 1991,36 : 29-34.
  • 8Krishnan M, Thodis E, Ikonomopoulos D, et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis.Petit Dial Int, 2002, 22:573-581.
  • 9Bibashi E, Memmos D, Kokolina E, et al. Fungal peritonitis complicating peritoneal dialysis during an l 1-year period:report of 46 cases. Clin Infect Dis, 2003, 36:927-931.
  • 10Taskapan H, Ozener C, Ates K, et al. The rate, risk factors, and outcome of fungal peritonitis in CAPD patients:experience in Turkey. Petit Dial Int, 2000, 20:338-341.

共引文献78

同被引文献121

引证文献13

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部